EQS-Adhoc: Relief Therapeutics Holding SA: Acer Therapeutics

Relief Therapeutics Holding SA / Key word(s): Study results Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Society for Inherited Metabolic Disorders Annual

Related Keywords

Geneva , Genè , Switzerland , Florida , United States , Secheron , Switzerland General , Orlando , Swiss , Jim Denike , Michael Miller , Hans Vitzthum , Raghuram Ram Selvaraju , Jack Weinstein , Advita Lifescience Gmb , Relief Therapeutics Holding Sa Key , Society For Inherited Metabolic Disorders , Pharma Research , Drug Administration , Swiss Exchange , Rx Communications Group , Nasdaq , Exchange Commission , European Medicines Agency , Relief Therapeutics Holding , Society For Inherited Metabolic Disorders Annual Meeting , News Service , Acer Therapeutics Inc , Neurorx Inc , Relief Therapeutics Announce Presentation , Inherited Metabolic Disorders Annual Meeting , Inherited Metabolic Disorders , Annual Meeting , Adrian Quartel , Prescription Drug User Fee Act , Taste Masked Sodium Phenylbutyrate , Urea Cycle Disorders Under Fasting , Fed Conditions , Masked Coating , Sodium Phenylbutyrate , Urea Cycle , Molecular Genetics , Maple Syrup Urine Disease , Vasomotor Symptoms , License Agreement , Vasoactive Intestinal Peptide , Acer Therapeutics , Maple Syrup Urine , Advita Lifescience Gmbh , Metabolism Reports , Private Securities Litigation Reform Act , Annual Report , Financial Officer , Adhoc , Relief , Herapeutics , Molding , Acer , Nnounce , Presentation , Data , Society , Ainherited , Etabolic , Disorders , Nnual , Meeting ,